Skip to content
2000
  • ISSN: 1568-0134
  • E-ISSN: 1568-0134

Abstract

The common syndrome of insulin resistance with hyperinsulinemia is frequently associated with a collection of metabolic abnormalities, including dyslipidemia, hypertension and diabetes. Lipodystrophy syndromes, which include both genetic and acquired forms, resemble the insulin resistance syndrome, particularly with respect to the presence of associated biochemical disturbances such as hyperlipidemia and diabetes. Since the discovery in 1999 that mutant LMNA causes Dunnigan-type partial lipodystrophy, human mutations in three other genes have been implicated in inherited lipodystrophy syndromes, namely PPARG in partial lipodystrophy, and AGPAT and BSCL2 in complete lipodystrophy. There is evidence for additional genetic heterogeneity for lipodystrophy syndromes. Delineation of the human molecular genetic basis of forms of inherited lipodystrophy may help to identify pathways and molecular targets for the common insulin resistance syndrome and for acquired drug-induced lipodystrophy syndromes.

Loading

Article metrics loading...

/content/journals/cmciema/10.2174/1568013023358799
2002-12-01
2025-10-02
Loading full text...

Full text loading...

/content/journals/cmciema/10.2174/1568013023358799
Loading

  • Article Type:
    Review Article
Keyword(s): Genetic Lipodystrophies; Insulin Resistance; LIPODYSTROPHY; THIAZOLADINEDIONES
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test